As of April 2, 2011 the New Jersey State Court system has almost 1,000 Reglan lawsuits centralized before Judge Carol Higbee. The majority of the 983 Reglan cases were filed since February 1, 2011.
In February 2009, the FDA required that Reglan and any generic versions of it add a black box warning; alerting patients and doctors of an increased risk of a tardive dyskinesia (TD). If used at high doses or over a long period of time, patients may develop TD, a disorder that causes involuntary movements of the face, such as grimacing, tongue thrusting, and rapid eye movements.
The sudden increase in lawsuits may have to do with a state law that requires claims to be filed within two years of a cause of action. Reglan lawsuits continue to be reviewed and filed by attorneys in other states, as laws can vary state to state.
